The global insulin market was valued at USD 20.35 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 1.5% from 2022 to 2030. The growth of the insulin market can be attributed to several key factors, including the rising incidence of diabetes and ongoing advancements in insulin formulations. However, the market's expansion could face challenges, particularly...